Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Nagata

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|May 10, 2019
The Differentiation <i>in vitro</i> of Human Tonsil B Cells With the Phenotypic and Functional Characteristics of T-bet+ Atypical Memory B Cells in MalariaAbhijit A Ambegaonkar, Satoshi Nagata, Susan K Pierce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicitySookhee Bang, Satoshi Nagata, Masanori Onda, et al.
Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.
Blood|September 27, 2007
FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxinsXing Du, Satoshi Nagata, Tomoko Ise, et al.
BMC Cancer|February 2, 2018
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modalityRick L Evans, James V Pottala, Satoshi Nagata, et al.
Scientific Reports|October 1, 2021
Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicingHiroki Akiba, Tomoko Ise, Satoshi Nagata, et al.
Biochemical and Biophysical Research Communications|June 14, 2002
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinaseGiuliana Salvatore, Satoshi Nagata, Marc Billaud, et al.
Angewandte Chemie (International Ed. in English)|June 1, 2023
A Proximity-Induced Fluorogenic Reaction Triggered by Antibody-Antigen Interactions with Adjacent EpitopesKentaro Nishiyama, Hiroki Akiba, Satoshi Nagata, et al.
Biochemical and Biophysical Research Communications|October 2, 2007
Palmitoylation of POTE family proteins for plasma membrane targetingSudipto Das, Tomoko Ise, Satoshi Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopesMasanori Onda, Richard Beers, Laiman Xiang, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|May 10, 2019
The Differentiation <i>in vitro</i> of Human Tonsil B Cells With the Phenotypic and Functional Characteristics of T-bet+ Atypical Memory B Cells in MalariaAbhijit A Ambegaonkar, Satoshi Nagata, Susan K Pierce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicitySookhee Bang, Satoshi Nagata, Masanori Onda, et al.
Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.
Blood|September 27, 2007
FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxinsXing Du, Satoshi Nagata, Tomoko Ise, et al.
BMC Cancer|February 2, 2018
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modalityRick L Evans, James V Pottala, Satoshi Nagata, et al.
Scientific Reports|October 1, 2021
Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicingHiroki Akiba, Tomoko Ise, Satoshi Nagata, et al.
Biochemical and Biophysical Research Communications|June 14, 2002
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinaseGiuliana Salvatore, Satoshi Nagata, Marc Billaud, et al.
Angewandte Chemie (International Ed. in English)|June 1, 2023
A Proximity-Induced Fluorogenic Reaction Triggered by Antibody-Antigen Interactions with Adjacent EpitopesKentaro Nishiyama, Hiroki Akiba, Satoshi Nagata, et al.
Biochemical and Biophysical Research Communications|October 2, 2007
Palmitoylation of POTE family proteins for plasma membrane targetingSudipto Das, Tomoko Ise, Satoshi Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopesMasanori Onda, Richard Beers, Laiman Xiang, et al.
Pageof 8